Vaccination responses in B-cell-depleted multiple sclerosis patients: The role of drug pharmacokinetics
Eur J Neurol
.
2022 Nov;29(11):3137-3138.
doi: 10.1111/ene.15529.
Epub 2022 Sep 9.
Authors
Joep Killestein
1
,
Zoé L E van Kempen
1
Affiliation
1
Department of Neurology, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
PMID:
35997630
PMCID:
PMC9538965
DOI:
10.1111/ene.15529
No abstract available
Keywords:
B-cell depletion; COVID-19; multiple sclerosis; rituximab; vaccination responses.
Publication types
Editorial
Comment
MeSH terms
B-Lymphocytes
Humans
Multiple Sclerosis* / drug therapy
Rituximab
Vaccination
Substances
Rituximab